330 related articles for article (PubMed ID: 24875753)
1. Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1.
Pantouris G; Serys M; Yuasa HJ; Ball HJ; Mowat CG
Amino Acids; 2014 Sep; 46(9):2155-63. PubMed ID: 24875753
[TBL] [Abstract][Full Text] [Related]
2. Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors.
Meininger D; Zalameda L; Liu Y; Stepan LP; Borges L; McCarter JD; Sutherland CL
Biochim Biophys Acta; 2011 Dec; 1814(12):1947-54. PubMed ID: 21835273
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
4. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
[TBL] [Abstract][Full Text] [Related]
5. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
[TBL] [Abstract][Full Text] [Related]
6. 1-L-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-D-methyltryptophan.
Yuasa HJ; Ball HJ; Austin CJ; Hunt NH
Comp Biochem Physiol B Biochem Mol Biol; 2010 Sep; 157(1):10-5. PubMed ID: 20399882
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
[TBL] [Abstract][Full Text] [Related]
8. Low efficiency IDO2 enzymes are conserved in lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable.
Yuasa HJ; Mizuno K; Ball HJ
FEBS J; 2015 Jul; 282(14):2735-45. PubMed ID: 25950090
[TBL] [Abstract][Full Text] [Related]
9. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation.
Qian F; Liao J; Villella J; Edwards R; Kalinski P; Lele S; Shrikant P; Odunsi K
Cancer Immunol Immunother; 2012 Nov; 61(11):2013-20. PubMed ID: 22527253
[TBL] [Abstract][Full Text] [Related]
11. High l-Trp affinity of indoleamine 2,3-dioxygenase 1 is attributed to two residues located in the distal heme pocket.
Yuasa HJ
FEBS J; 2016 Oct; 283(19):3651-3661. PubMed ID: 27522067
[TBL] [Abstract][Full Text] [Related]
12. Methylene blue and ascorbate interfere with the accurate determination of the kinetic properties of IDO2.
Yuasa HJ; Stocker R
FEBS J; 2021 Aug; 288(16):4892-4904. PubMed ID: 33686747
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease.
Fatokun AA; Hunt NH; Ball HJ
Amino Acids; 2013 Dec; 45(6):1319-29. PubMed ID: 24105077
[TBL] [Abstract][Full Text] [Related]
14. Heme-containing enzymes and inhibitors for tryptophan metabolism.
Yan D; Lin YW; Tan X
Metallomics; 2017 Sep; 9(9):1230-1240. PubMed ID: 28650043
[TBL] [Abstract][Full Text] [Related]
15. Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase.
Winters M; DuHadaway JB; Pham KN; Lewis-Ballester A; Badir S; Wai J; Sheikh E; Yeh SR; Prendergast GC; Muller AJ; Malachowski WP
Eur J Med Chem; 2019 Jan; 162():455-464. PubMed ID: 30469041
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the Tissue Distribution and Physiological Roles of Indoleamine 2,3-Dioxygenase-2.
Jusof FF; Bakmiwewa SM; Weiser S; Too LK; Metz R; Prendergast GC; Fraser ST; Hunt NH; Ball HJ
Int J Tryptophan Res; 2017; 10():1178646917735098. PubMed ID: 29051706
[TBL] [Abstract][Full Text] [Related]
17. Substrate Oxidation by Indoleamine 2,3-Dioxygenase: EVIDENCE FOR A COMMON REACTION MECHANISM.
Booth ES; Basran J; Lee M; Handa S; Raven EL
J Biol Chem; 2015 Dec; 290(52):30924-30. PubMed ID: 26511316
[TBL] [Abstract][Full Text] [Related]
18.
Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma.
Yamasuge W; Yamamoto Y; Fujigaki H; Hoshi M; Nakamoto K; Kunisawa K; Mouri A; Nabeshima T; Saito K
Cancer Sci; 2019 Oct; 110(10):3061-3067. PubMed ID: 31444833
[TBL] [Abstract][Full Text] [Related]
20. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]